Complete Wegovy vs Mounjaro Mechanism & Pricing Breakdown
What's Better Wegovy or Mounjaro: Understanding the Core Mechanisms
When evaluating what's better Wegovy or Mounjaro, the fundamental difference lies in their hormonal targets. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone, working specifically on brain appetite centres to reduce cravings and promote satiety after smaller meals. Mounjaro utilises tirzepatide, a dual agonist that targets both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 receptors simultaneously, potentially offering a broader metabolic approach. This dual mechanism may explain why some patients experience different responses between the treatments, though individual results vary significantly based on personal physiology and adherence to the accompanying reduced-calorie diet and increased physical activity required for both medications. Both prescription-only medicines work by slowing gastric emptying and influencing neural pathways that control hunger and food intake.
The question of what's better Wegovy or Mounjaro cannot be answered universally, as each patient's response depends on factors including baseline weight, comorbidities, tolerance to side effects, and lifestyle factors. Wegovy follows a structured 5-dose escalation protocol (0.25mg to 2.4mg maintenance), while Mounjaro uses a 6-dose schedule reaching up to 15mg weekly. Clinical trials show both medications can support significant weight management when combined with comprehensive lifestyle interventions, but direct head-to-head comparisons are limited due to different trial designs and patient populations. At EverydayMeds, our clinical team helps patients understand these nuances during the prescribing process. Your individual medical history, current medications, and treatment goals will influence whether Wegovy or Mounjaro proves more suitable for your circumstances.
Wegovy vs Mounjaro Pricing Comparison and Value Analysis
Understanding the cost implications helps answer what's better Wegovy or Mounjaro from a financial perspective. Wegovy pricing starts at £79.99 for the 0.25mg starter dose (after applying discount code FIRST40 for new customers), progressing to £94.99 for 0.5mg, £99.99 for 1mg, £139.99 for 1.7mg, and £209.99 for the 2.4mg maintenance dose. Our bundle options provide convenience for dose progression, with the Intro Trio (0.25mg, 0.5mg, and 1mg) available for £299.99, ensuring you have the necessary doses for your first three months without multiple orders. Mounjaro follows a different pricing structure reflecting its distinct dosing schedule, with both medications requiring the same rigorous clinical assessment and next-day cold-chain delivery from our GPhC-registered pharmacy #9012878. Returning customers benefit from code DOSE25 applied at checkout, making ongoing treatment more affordable across both medication options.
When comparing what's better Wegovy or Mounjaro financially, consider the total treatment duration and dose requirements rather than individual pen costs. Both medications typically require several months of treatment to achieve optimal results, with most patients remaining on maintenance doses long-term for sustained weight management. The EverydayMeds Ultimate Stability Trio provides three months of Wegovy 2.4mg maintenance supply for £649.99, offering predictable monthly costs once you've reached your effective dose. Bundle purchases provide convenience benefits including Reliable Supply continuity, reduced ordering frequency, and single temperature-controlled deliveries. Your prescriber will help determine the most cost-effective approach based on your expected treatment timeline and response to initial doses.
Clinical Evidence: What's Better Wegovy or Mounjaro Based on Research
The clinical evidence supporting both medications comes from separate trial programmes, making direct comparisons challenging when determining what's better Wegovy or Mounjaro. Wegovy's efficacy was demonstrated in the STEP trial programme, where patients taking semaglutide alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks compared to 2.4% with placebo in STEP 1 (Wilding et al., NEJM, 2021). The STEP 5 extension showed sustained weight loss of approximately 15.2% maintained over two years with continued treatment. Mounjaro's clinical programme utilised different endpoints and patient populations, making percentage comparisons inappropriate and potentially misleading for patient decision-making.
Both medications demonstrated efficacy in their respective clinical programmes when used alongside comprehensive lifestyle interventions including reduced-calorie diet and increased physical activity. The STEP trials enrolled adults with BMI ≥30 or BMI ≥27 with weight-related comorbidities, matching Wegovy's current UK licensing conditions. Individual responses vary considerably, with some patients experiencing greater benefit from one medication over another due to genetic factors, baseline metabolism, and adherence patterns. Your EverydayMeds prescriber will evaluate your medical history and treatment goals to determine which clinical profile aligns better with your circumstances when deciding what's better Wegovy or Mounjaro for your individual situation.
How Wegovy Works: GLP-1 Receptor Mechanism Explained
Wegovy works by mimicking GLP-1 (glucagon-like peptide-1), a natural hormone released by intestinal cells in response to food intake. When you inject Wegovy weekly using the FlexTouch pre-filled pen, semaglutide binds to GLP-1 receptors in multiple tissues including the brain, stomach, and pancreas. In the hypothalamus, this binding reduces appetite signals and increases feelings of satiety, helping you feel full after consuming smaller portions than usual. The medication also slows gastric emptying, meaning food remains in your stomach longer, contributing to sustained fullness between meals. Additionally, GLP-1 receptor activation may reduce food cravings and the reward response associated with high-calorie foods, though individual experiences vary. This multi-target approach explains why Wegovy must be combined with dietary changes and increased physical activity to achieve optimal weight management results as demonstrated in clinical trials.
EverydayMeds Ordering Process: From Assessment to Delivery
Starting treatment with either Wegovy or Mounjaro through EverydayMeds begins with our comprehensive 3-minute online clinical assessment, designed to capture essential medical history, current medications, and weight management goals. Our qualified prescribers review each assessment within 3 working days (or 24 hours with express service), ensuring appropriate prescribing based on MHRA licensing criteria and NICE guidelines. Once approved, your prescription-only medicine ships via next-day delivery using specialist cold-chain transport to maintain the required 2-8°C temperature throughout transit. All packages include temperature monitoring devices and insulated packaging to ensure medication integrity upon arrival. Our clinical team remains available for ongoing support, dose adjustment discussions, and any questions about transitioning between treatments if your initial choice requires modification based on tolerance or efficacy outcomes.
Storage and Practical Considerations: Wegovy vs Mounjaro Differences
Storage requirements present a practical advantage when considering what's better Wegovy or Mounjaro for your lifestyle. Wegovy can remain at room temperature (below 30°C) for up to 6 weeks once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit, making Wegovy more suitable for extended travel or irregular refrigeration access. Both medications require initial storage at 2-8°C and use pre-filled pen devices for weekly self-injection, typically in the thigh, abdomen, or upper arm. The FlexTouch pen design used for Wegovy features a large, clear dose counter and requires no assembly or loading, while both medications follow similar injection techniques. Dose escalation schedules differ significantly: Wegovy requires 5 distinct dose increases over 16 weeks, while Mounjaro follows a 6-dose progression, affecting your ordering schedule and medication management routine. These practical factors may influence treatment preference depending on your travel patterns, storage capabilities, and comfort with medication management protocols.
Why Choose Between Wegovy vs Mounjaro When You Can Access Both
The unique advantage of choosing EverydayMeds for weight management lies in our comprehensive stock of both leading treatments, eliminating the need to commit to one option without clinical guidance. Many patients benefit from trying one medication initially, then switching if tolerance issues arise or efficacy proves suboptimal after adequate trial periods. Our prescribers can facilitate such transitions based on your individual response, side effect profile, and changing medical circumstances. Having both options readily available means no treatment delays if medication switching becomes necessary during your weight management journey.
This dual availability particularly benefits patients with complex medical histories who may respond differently to GLP-1-only versus dual agonist mechanisms. Rather than forcing a choice based on limited information, our clinical team can guide evidence-based decision-making tailored to your specific situation. The question of what's better Wegovy or Mounjaro becomes less relevant when you have access to both treatments through a single, trusted provider with ongoing clinical support throughout your treatment journey.
Start Your Weight Management Journey: Both Options Available Now
Ready to begin treatment but still unsure about what's better Wegovy or Mounjaro for your specific needs? Our clinical assessment captures the information necessary for your prescriber to recommend the most appropriate starting treatment based on your medical history, lifestyle factors, and treatment preferences. Use code FIRST40 for new customers or DOSE25 for returning patients at checkout to access our competitive pricing on both medications. Complete your assessment today at https://everydaymeds.co.uk/collections/weight-loss to receive expert guidance on choosing between these two leading weight management options. Our GPhC-registered pharmacy #9012878 ensures you receive genuine, temperature-controlled medications with complete clinical support. Remember that both Wegovy and Mounjaro require commitment to lifestyle changes including reduced-calorie diet and increased physical activity for optimal results, and your EverydayMeds clinical team will provide ongoing support throughout your treatment journey.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
